Sabra Health Care REIT (SBRA) EPS (Weighted Average and Diluted) (2011 - 2026)

Sabra Health Care REIT's EPS (Weighted Average and Diluted) history runs 16 years deep, the most recent figure standing at $0.16 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) fell 5.88% year-over-year to $0.16; the TTM figure through Mar 2026 stood at $0.63 (up 5.0% YoY), while the FY2025 annual figure was $0.64, up 18.52% from the prior year.
• EPS (Weighted Average and Diluted) was $0.16 for Q1 2026 at Sabra Health Care REIT, up from $0.11 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.27 in Q2 2025 to a low of -$0.37 in Q4 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.06 across 5 years, with a median of $0.1 in 2024.
• The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) sank 540.0% in 2022, then surged 375.0% in 2024.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.37 in 2022, then jumped by 118.92% to $0.07 in 2023, then soared by 185.71% to $0.2 in 2024, then sank by 45.0% to $0.11 in 2025, then surged by 45.45% to $0.16 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.16 (Q1 2026), $0.11 (Q4 2025), and $0.09 (Q3 2025), per Business Quant data.